PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR PEPTIDE DRUG DELIVERY SYSTEM-DESIGN

被引：9
|
作者：
BREIMER, DD
机构：
[1] Center for Bio-Pharmaceutical Sciences, Leiden University, Leiden
来源：
JOURNAL OF CONTROLLED RELEASE | 1992年 / 21卷 / 1-3期
关键词：
NEW DRUG DELIVERY; PHARMACOKINETICS; PHARMACODYNAMICS; PEPTIDE AND PROTEIN DRUGS;
D O I：
10.1016/0168-3659(92)90003-A
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：5 / 10
页数：6
相关论文
共 50 条
  • [11] Pharmacokinetic and Pharmacodynamic Basis for Effective Argatroban Dosing in Pediatrics
    Madabushi, Rajanikanth
    Cox, Donna S.
    Hossain, Mohammad
    Boyle, Duane A.
    Patel, Bela R.
    Young, Guy
    Choi, Young-Moon
    Gobburu, Jogarao V. S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) : 19 - 28
  • [12] Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
    Klimontov, V. V.
    Myakina, N. E.
    DIABETES MELLITUS, 2014, 17 (04): : 99 - 107
  • [13] Theoretical pharmacokinetic and pharmacodynamic simulations of drug delivery mediated by blood-brain barrier transporters
    Doan, KMM
    Boje, KMK
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2000, 21 (07) : 261 - 278
  • [14] Pharmacokinetic/Pharmacodynamic-Driven Drug Development
    Gallo, James M.
    MOUNT SINAI JOURNAL OF MEDICINE, 2010, 77 (04): : 381 - 388
  • [15] Pharmacokinetic/pharmacodynamic studies in drug product development
    Meibohm, B
    Derendorf, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (01) : 18 - 31
  • [16] A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone
    Mason, BJ
    Goodman, AM
    Dixon, RM
    Hameed, MHA
    Hulot, T
    Wesnes, K
    Hunter, JA
    NEUROPSYCHOPHARMACOLOGY, 2002, 27 (04) : 596 - 606
  • [17] A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
    Barbara J Mason
    Anita M Goodman
    Russell M Dixon
    Magdy H Abdel Hameed
    Thierry Hulot
    Keith Wesnes
    John A Hunter
    Michael G Boyeson
    Neuropsychopharmacology, 2002, 27 : 596 - 606
  • [18] Role of the pharmacokinetic-pharmacodynamic relationship in drug development
    Bellissant, E
    Courcier-Duplantier, S
    Blin, O
    THERAPIE, 2002, 57 (04): : 347 - 357
  • [19] Design and evaluation of novel natriuretic peptide derivatives with improved pharmacokinetic and pharmacodynamic properties
    Morozumi, Naomi
    Sato, Seiji
    Yoshida, Sayaka
    Harada, Yuriko
    Furuya, Mayumi
    Minamitake, Yoshiharu
    Kangawa, Kenji
    PEPTIDES, 2017, 97 : 16 - 21
  • [20] Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill
    Tsai, Danny
    Lipman, Jeffrey
    Roberts, Jason A.
    CURRENT OPINION IN CRITICAL CARE, 2015, 21 (05) : 412 - 420
12345